Filter News
Area of Research
- (-) Materials (11)
- Advanced Manufacturing (2)
- Biology and Environment (9)
- Clean Energy (12)
- Computational Engineering (1)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (9)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (6)
- Materials for Computing (2)
- National Security (9)
- Neutron Science (6)
- Nuclear Science and Technology (8)
- Supercomputing (16)
News Topics
- (-) Artificial Intelligence (4)
- (-) Biomedical (3)
- (-) Isotopes (5)
- (-) Machine Learning (2)
- (-) Nuclear Energy (2)
- (-) Transformational Challenge Reactor (1)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (1)
- Bioenergy (8)
- Biology (4)
- Buildings (2)
- Chemical Sciences (20)
- Climate Change (5)
- Composites (3)
- Computer Science (8)
- Coronavirus (2)
- Critical Materials (8)
- Cybersecurity (3)
- Decarbonization (4)
- Energy Storage (19)
- Environment (7)
- Exascale Computing (1)
- Frontier (2)
- Fusion (2)
- Grid (2)
- High-Performance Computing (2)
- ITER (1)
- Materials (38)
- Materials Science (35)
- Microscopy (12)
- Molten Salt (2)
- Nanotechnology (21)
- National Security (3)
- Net Zero (1)
- Neutron Science (18)
- Partnerships (8)
- Physics (14)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (10)
- Renewable Energy (1)
- Security (1)
- Summit (1)
- Sustainable Energy (7)
- Transportation (4)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.